Breast Cancer Molecular Diagnostics Market size is estimated to be USD 5.8 Billion in 2024 and is expected to reach USD 13.5 Billion by 2033 at a CAGR of 9.9% from 2026 to 2033.
The global breast cancer molecular diagnostics market was valued at approximately USD 3.8 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2030. This growth is driven by an increasing number of breast cancer cases, advancements in molecular diagnostic technologies, and growing awareness about early detection. Additionally, increasing adoption of personalized medicine and the rising number of government initiatives for breast cancer awareness are expected to fuel market growth. The North American region accounted for the largest share of the market in 2022, driven by the presence of key healthcare infrastructure, rising healthcare expenditure, and well established reimbursement policies for molecular diagnostics. The region is anticipated to maintain dominance through the forecast period, contributing significantly to the global market revenue.
Regionally, Europe and the Asia Pacific are also expected to see substantial growth in the breast cancer molecular diagnostics market, with a CAGR of 9.2% and 8.1%, respectively, during the forecast period. Europe’s market is being propelled by increasing healthcare investments, the rising prevalence of breast cancer, and a robust regulatory framework. The Asia Pacific region is witnessing a surge in demand for molecular diagnostics, particularly in emerging economies like China and India, where the rising burden of cancer and increasing healthcare awareness are key drivers. Furthermore, the Latin American and Middle Eastern markets are expected to grow steadily due to improving healthcare facilities and government healthcare initiatives aimed at cancer prevention and treatment. The market is poised for considerable expansion as molecular diagnostic tools gain popularity across different regions globally.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=761986&utm_source=Pulse_G_April&utm_medium=226
Â
Roche
Qiagen
Illumina
Abbott
Oncotypeiq
BD
Tellgen
Genetech
Gpmedical
Zeesan
Sansure
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=761986&utm_source=Pulse_G_April&utm_medium=226
Growing demand for below applications around the world has had a direct impact on the growth of the Global Breast Cancer Molecular Diagnostics Market
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
In Situ Hybridization (ISH)
Microarray
Immunohistochemistry (IHC)
Genetic Tests
Protein Biomarker Tests
Pathology Tests
Liquid Biopsy Tests
Proteomic Tests
Diagnosis
Prognosis
Treatment Monitoring
Recurrence Monitoring
Risk Assessment
Hospitals
Diagnostic Laboratories
Research Institutes
Oncology Clinics
Pharmaceutical and Biotechnology Companies
Hormonal (Estrogen and Progesterone Receptors)
HER2/neu (Human Epidermal Growth Factor Receptor 2)
Genetic Mutations (e.g., BRCA1 and BRCA2)
Circulating Tumor Cells (CTCs)
Genetic Markers
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/breast-cancer-molecular-diagnostics-market/
1. Introduction of the Global Breast Cancer Molecular Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Breast Cancer Molecular Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Breast Cancer Molecular Diagnostics Market, By Type
6. Global Breast Cancer Molecular Diagnostics Market, By Application
7. Global Breast Cancer Molecular Diagnostics Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Breast Cancer Molecular Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/